🇺🇸 FDA
Pipeline program

Cisplatin

GORTEC 2018-01

Phase 3 small_molecule active

Quick answer

Cisplatin for Squamous Cell Carcinoma of Head and Neck is a Phase 3 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Squamous Cell Carcinoma of Head and Neck
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials